Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by simouuunon Sep 03, 2015 7:13am
281 Views
Post# 24074374

BO after approval? Could be expensive.

BO after approval? Could be expensive. Valeant aquired Sprout (Addyi) for 1.3 billion with milestone payments, after approval. Raghuram Selvaraju, managing director of brokerage H.C. Wainwright & Co, has estimated peak sales of $100 million a year for Addyi.

Telesta: US peak market estimate >US$400 million after approval of MCNA.

You know what I mean? ....

<< Previous
Bullboard Posts
Next >>